A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome

Pure white cell aplasia (PWCA) is a rare manifestation of thymoma. It is characterized by agranulocytosis with absent myeloid precursors in the bone marrow and normal hematopoiesis for other cell lines. Here we describe a 65-year-old female patient who presented with three days of fever and night sw...

Full description

Bibliographic Details
Main Authors: Kim Uy, Elizabeth Levin, Pawel Mroz, Faqian Li, Surbhi Shah
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/1024670
id doaj-d1ea493d0efe483c8ccfa1c9d344f80b
record_format Article
spelling doaj-d1ea493d0efe483c8ccfa1c9d344f80b2020-11-25T01:49:08ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/10246701024670A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s SyndromeKim Uy0Elizabeth Levin1Pawel Mroz2Faqian Li3Surbhi Shah4University of Minnesota, Department of Medicine, Division of Hematology, Oncology and Transplantation, Minneapolis, MN, USAUniversity of Minnesota, Department of Medicine, Division of Hematology, Oncology and Transplantation, Minneapolis, MN, USAUniversity of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, USAUniversity of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, USAUniversity of Minnesota, Department of Medicine, Division of Hematology, Oncology and Transplantation, Minneapolis, MN, USAPure white cell aplasia (PWCA) is a rare manifestation of thymoma. It is characterized by agranulocytosis with absent myeloid precursors in the bone marrow and normal hematopoiesis for other cell lines. Here we describe a 65-year-old female patient who presented with three days of fever and night sweat. Chest CT revealed an anterior mediastinal mass. A biopsy of the mass confirmed a diagnosis of thymoma mixed type A and B2. The patient developed a severe neutropenia, and her bone marrow revealed significantly decreased neutrophil-lineage cells, rare to absent B cells, and defective T cells, consistent with PWCA. Following thymectomy, a complete resolution of PWCA was achieved via multimodality therapy of intravenous immunoglobulins, granulocyte colony-stimulating factor, and immunosuppressant. This report highlights the care complexity regarding treatment choices and decision to perform thymectomy in patients presenting with PWCA.http://dx.doi.org/10.1155/2019/1024670
collection DOAJ
language English
format Article
sources DOAJ
author Kim Uy
Elizabeth Levin
Pawel Mroz
Faqian Li
Surbhi Shah
spellingShingle Kim Uy
Elizabeth Levin
Pawel Mroz
Faqian Li
Surbhi Shah
A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
Case Reports in Hematology
author_facet Kim Uy
Elizabeth Levin
Pawel Mroz
Faqian Li
Surbhi Shah
author_sort Kim Uy
title A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
title_short A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
title_full A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
title_fullStr A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
title_full_unstemmed A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome
title_sort rare complication of thymoma: pure white cell aplasia in good’s syndrome
publisher Hindawi Limited
series Case Reports in Hematology
issn 2090-6560
2090-6579
publishDate 2019-01-01
description Pure white cell aplasia (PWCA) is a rare manifestation of thymoma. It is characterized by agranulocytosis with absent myeloid precursors in the bone marrow and normal hematopoiesis for other cell lines. Here we describe a 65-year-old female patient who presented with three days of fever and night sweat. Chest CT revealed an anterior mediastinal mass. A biopsy of the mass confirmed a diagnosis of thymoma mixed type A and B2. The patient developed a severe neutropenia, and her bone marrow revealed significantly decreased neutrophil-lineage cells, rare to absent B cells, and defective T cells, consistent with PWCA. Following thymectomy, a complete resolution of PWCA was achieved via multimodality therapy of intravenous immunoglobulins, granulocyte colony-stimulating factor, and immunosuppressant. This report highlights the care complexity regarding treatment choices and decision to perform thymectomy in patients presenting with PWCA.
url http://dx.doi.org/10.1155/2019/1024670
work_keys_str_mv AT kimuy ararecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT elizabethlevin ararecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT pawelmroz ararecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT faqianli ararecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT surbhishah ararecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT kimuy rarecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT elizabethlevin rarecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT pawelmroz rarecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT faqianli rarecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
AT surbhishah rarecomplicationofthymomapurewhitecellaplasiaingoodssyndrome
_version_ 1725008700035301376